Childbirth pain relief to insulin: shortage of drugs ‘putting patients at risk’
Pharmacist says low supplies of medication means they are ‘always firefighting’

Pharmacists have warned that a shortage of some medicines is putting patients at risk.
A survey of 1,562 UK pharmacists for The Pharmaceutical Journal found that 54% believed patients had been put at risk in the past six months due to shortages.
One pharmacist working in a GP practice in England told the publication that they were “always firefighting”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
“Presently, hardly a week goes by without at least one pharmacy asking us to give an alternative,” they said, adding that this can be “quite dangerous” and “creates a lot of stress to both patients and professionals alike”.
Sky News said that the government has issued a number of “medicine supply notifications”, highlighting shortages of certain drugs, including one used by prostate cancer patients, an antipsychotic drug used among bipolar disorder and schizophrenia patients, and a certain brand of insulin.
The NHS is also said to be facing a shortage of epidural kits, a key form of pain relief during childbirth, as well as Remifentanil, a painkiller that women are offered as an alternative.
Supplies of both are so low that some hospitals are no longer able to offer pregnant women the standard right to choose which one they want to reduce labour pains, said The Guardian.
Anaesthetists told the paper that this has led to “difficult discussions” with women who had been told they would be given a choice.
A Department of Health and Social Care spokesperson said it works “closely with industry, the NHS and others to prevent shortages and resolve any issues as soon as possible”.
There have also been shortages overseas. The European Medicines Agency has experienced low supplies of a drug that is used frequently in IVF procedures, said Endpoints News.
Meanwhile, Australia faces “dire” medicine shortages, with more than 300 drugs in short supply, said The Guardian.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
June 1 editorial cartoons
Cartoons Sunday's political cartoons include Donald Trump's golden comb-over, brain drain in America, and a new TACO presidential seal.
-
5 cartoons about the TACO trade
Cartoons Political cartoonists take on America's tariffs, Vladimir Putin waiting for taco Tuesday, and a new presidential seal
-
A city of culture in the high Andes
The Week Recommends Cuenca is a must-visit for those keen to see the 'real Ecuador'
-
How the care industry came to rely on migrant workers
The Explainer Government crackdown on recruiting workers abroad risks deepening care sector crisis, industry leaders warn
-
Could medics' misgivings spell the end of the assisted dying bill?
Today's Big Question The Royal College of Psychiatrists has identified 'serious concerns' with the landmark bill – and MPs are taking notice
-
Washwood Heath: Birmingham's pioneering neighbourhood health service
In the Spotlight NHS England chair says there is a 'really good argument this is the model for the future'
-
The UK's first legal drug consumption room
The Explainer 'Potentially transformative moment in UK drugs policy' as The Thistle opens in Glasgow
-
How can the UK solve the adult social care crisis?
Today's Big Question New commission announced to turn our buckling care sector around: yet more delay or finally a way forward?
-
Should blood donors be paid?
The Explainer Financial rewards would help fill NHS shortfall but bring risk of contamination and exploitation, WHO warns
-
UK gynaecological care crisis: why thousands of women are left in pain
The Explainer Waiting times have tripled over the past decade thanks to lack of prioritisation or funding for women's health
-
A 'transformative' gene therapy for haemophilia B
The Explainer Costly treatment that could be 'truly life-changing' for patients with rare blood disorder gets funding boost